Study of Surufatinib as Second-line Treatment in Patients With Biliary Tract Carcinoma
Clinical trial NCT02966821 · COMPLETED
Trial details
- NCT number
- NCT02966821
- Sponsor
- Hutchison Medipharma Limited
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-01-03
- Primary completion
- 2018-08-17
- Enrollment
- 39
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.